Hydrochlorothiazide Capsule
Product Images NDC 51655-522

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Hydrochlorothiazide (NDC 51655-522). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure Of Hydrochlorothiazide (499f2d9f 9fa0 4b30 8115 Ff9e932abc04 01)

Chemical structure of hydrochlorothiazide, showing a benzothiadiazine ring system with chlorine, sulfonamide, and secondary amine functional groups.*

FDA Label Image

Company Logo (499f2d9f 9fa0 4b30 8115 Ff9e932abc04 02)

FDA Label Image

Label (51655 522 52 Master Bottle Label Approval Rev A 06 22)

Label for hydrochlorothiazide capsules USP 12.5 mg, containing 30 capsules. The label specifies prescription use only, storage instructions at controlled room temperature, and precautions for protecting from light, moisture, and freezing. Manufactured and repackaged by Northwind Pharmaceuticals (USA), Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.